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Factors Affecting Sertoli Cell Function
in the Testis
by D. J. Tindall,* J. S. Tash,* and A. R. Means*
The Sertoli cell is the primary target for FSH action in the mammalian testis. These cells
contain the majority of testicular plasma membrane receptors for this hormone. Receptor
occupancy is directly correlated with a stimulation of adenylyl cyclase and a decrease in the
activityofacytoplasmicCa ++-sensitivecAMPphosphodiesterase.Regulationofthesetwoenzymes
allows increased intracellular accumulation of cAMP, activation of cAMP-dependent protein
kinase and phosphorylation ofavariety ofprotein substrates. All ofthese events occurwithin the
first 30 min following exposure of isolated Sertoli cells to FSH.
RNA and protein synthesis are also enhanced by FSH. Previous studies have suggested that
this gonadotropin may augment the overall cellular synthesis ofproteins. Our results reveal that
protein kinase inhibitor (PKI) is selectively elevated by FSH both in vivo and in vitro. PKI thus
becomes the initial intracellular protein whose synthesis is under FSH control. In addition to
effects on protein synthesis, FSH also positively modulates the secretion of several specific
proteins. One of the proteins in this latter category is androgen binding protein (ABP). Again,
regulation can be observed both in vivo and in vitro. Elevated synthesis of PKI occurs prior to
demonstrable secretion ofABP. Both ofthese events occur subsequent to the effects ofFSH on
cAMP metabolism. Indeed cAMP (or any of several nonhydrolyzable derivatives) can substitute
for FSH in vitro. The temporal sequence of events subsequent to hormone binding and cAMP
production are identical, but occur more rapidly. Together these data support the hypothesisthat
most of the biochemical steps leading to the synthesis and secretion of proteins by FSH are
regulated by elevated levels of cAMP.
Introduction
The effects of toxic agents on the testis can be
evaluated only by understanding the basic biologi-
cal events which contribute to the normal functions
within the testis. The Sertoli cell, to a large degree,
dictates the development and maintenance of sper-
matogenesis within the testis. The Sertoli cell is
regulated by both a steroid hormone, testosterone,
and a peptide hormone, follicle stimulating hor-
mone (FSH). Spermatogenesis is probably medi-
ated by the action ofthese two hormones on Sertoli
cells. By understanding the basic mechanisms by
which hormones regulate the Sertoli cell and by
identifying specific proteins which are themselves
regulated by hormones we can begin to evaluate
mechanisms by which toxic agents might be affect-
ing spermatogenesis. Several recent reviews con-
cern the hormonal regulation of spermatogenesis
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and the mechanism of action of FSH (1-3). In this
article we will review three areas ofFSH action: (a)
The temporal sequence ofevents following addition
of FSH to Sertoli cells in culture; (b) The stimula-
tion of the synthesis of protein kinase inhibitor in
the Sertoli cell; and (c) The hormonal regulation of
androgen binding protein in Sertoli cells.
Mechanism of FSH Action
A proposed sequence ofevents for FSH action in
the Sertoli cell is presented in Figure 1. FSH binds
to specific receptors on the membranes of Sertoli
cells (4-6). This interaction is both tissue- and
cell-specific, is dependent on both temperature and
time,isofhighaffinity(Kd =10"1 M), andisoflimited
capacity (104 sites per cell). Binding of [125_] or
[3H]FSH can be detected within 1 min, and satura-
tion is achieved by 20 min. FSH-membrane binding
coincides with stimulation ofadenylyl cyclase (3, 7,
8). Cyclase stimulation can be observed either in
5homogenates prepared from Sertoli cells, intact
Sertoli cells incubated with [ot32P]ATP, or in mem-
branes isolated from the cultured Sertoli cells (8).
In the latter case, a significant stimulation is noted
within 2 min, and a linear increase in activity
continues for at least 20 min. Thus, the temporal
kinetics of the interaction of FSH with plasma
membrane receptors and the activation of mem-
brane bound adenylyl cyclase are similar.
Adenylyl cyclase is the only enzyme known to
synthesize cyclic AMP (cAMP) in cells. Likewise,
cyclic nucleotide-dependent phosphodiesterase is
the only enzyme to degrade cAMP. A change in the
Vmax of adenylyl cyclase is equal to an equivalent
change in the Km of phosphodiesterase, which is
inversely related to the V ax of phosphodiesterase
(3). Therefore, in consicering the steady-state
concentration of cAMP, activities of phosphodies-
terase must be taken into account. Administration
ofFSH result,s in adecrease in the activity ofcAMP
phosphodiesterase in isolated Sertoli cells within 5
min; inhibition is maximal at 20 min (3, 4, 9). The
temporal effects of FSH on phosphodiesterase are
similar to FSH binding and stimulation of adenylyl
cyclase. The phosphodiesterase isoform affected by
FSH is a hi h affinity cAMP enzyme that requires
calcium (10- M) for activity (3). The stimulation of
adenylyl cyclase and inhibition ofphosphodiesterase
result in an elevation ofintracellular levels ofcAMP
(10). Significant effects can be seen at 1011 M
hormone, and maximal effects occur at 10-9 M (4).
Thus over a two log dose range of FSH, a linear
increase in Sertoli cell cAMP is observed.
The increase in the intracellular concentration of
cAMP results in the activation ofcAMP-dependent
protein kinase (2-4, 8, 11). This activation can be
seen within 2 min, is maximal within 30 min, and
even in the continued presence ofh6rmone declines
to basal levels by 4 hr. The activated catalytic
subunit of cAMP-dependent protein kinase phos-
phorylates proteins in virtually every subcellular
compartment. Subsequent to the biological events
described above, increased activity of RNA syn-
thesis, protein synthesis and protein secretion are
observed (3).
FSH Stimulation of Protein Kinase
Inhibitor
The heat-stable inhibitor of cAMP-dependent
protein kinase (PKI) has been demonstrated to be
under specific hormonal regulation by FSH in vivo
(12-15). Significant increases in inhibitor activity in
younganimals were detectable as early as 8 hr after
hormone administration, maximal levels (twofold
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FIGURE 1. Proposed sequence of events for FSH action in the
Sertoli cell.
increase) were achieved 24 hr after FSH treat-
ment. Stimulation of PKI was specific to FSH;
neither luteinizing hormone (LH) nor testosterone
propionate could induce any change in testicular
PKI activity. FSH stimulationofPKI wasprevented
if protein synthesis was blocked by administration
of cycloheximide.
Sertoli cells cultured for 3 days in the continued
presence of 5 ,ug FSH/ml (NIH-S-12) and 5% rat
serum contained significantly higher levels of PKI
than cultures maintained in the absence of FSH
(12). Culture conditions have been so modified that
cells are maintained in completely defined medium
in the absence of serum. Under these conditions in
the absence of FSH, PKI activity in cells isolated
from 16-day old cells drops markedly during the
first 24 hr of culture. The low level of inhibitor
activity reached after one day remains unchanged
during the remainder of the 4-day culture period.
When Sertoli cells were cultured for 2-3 days in
completely defined medium, it was found that the
continued presence ofFSH resulted in a 5- to 7-fold
greater level of PKI activity than cells cultured for
the same period of time in the absence of hormone
(14). On the other hand, when cells were first
cultured for 1 or 2 days without hormone, PKI
activity declined. Subsequent exposure to FSH
initiated a significant 3- to 4- fold stimulation in PKI
activity (13).
The ability of FSH to maintain PKI activity in
Sertoli cells (from 16-day old rats) was found to be
dependent on the concentration of FSH (Fig. 2).
Maximal PKI activity was observed in cultures
containing 500 ng FSH/ml; half-maximal levels
were achieved with as little as 80 ng FSH/ml (14).
Environmental Health Perspectives.z
z
E
a,
E
01
Q-
FSH (ng/ml)
FIGURE 2. Dose-dependent maintenance and stimulation of
PKI by FSH. Sertoli cells (from 18-day old animals) were
cultured (0) for three days in the presence of FSH or (-) for
two days in the absence of FSH followed by 24 hr in the
presence ofFSH (O to 5 ,ug/ml). PKI activity was determined
at each point in triplicate culture plates ± SEM (15).
The time course of PKI stimulation by FSH was
next examined. Sertoli cells from 16-day old rats
were cultured from two days without FSH, then for
24 hr with 500 ng/ml FSH. PKI activity was
measured at 0, 2, 4, 8, 12, and 24 hr after hormone
addition. A time-dependent increase in PKI levels
occurred uponaddition ofFSH (Fig. 3). Asignificant
increase in PKI activity (68%) was observed 4 hr
after addition of FSH; by 24 hr PKI activity had
increased 4-fold over control cultures not treated
with FSH (14).
The stimulation by FSH of PKI in Sertoli cells
from 16-day old rats can be mimicked by dibutyryl
cAMP. A significant increase in PKI activity was
observed only 2 hr after addition ofdibutyryl cAMP
(1 x 10-4 M) to the culture medium. Near maximal
stimulation ofinhibitor levels was obtained by 8 hr
after dibutyryl cAMP addition (14).
The hormone specificity of the stimulation of
Sertoli cell PKI was next examined. Cells from
16-day old animals were cultured for two days
without hormone, then for 24 hr in the presence of
FSH (500 ng/ml), LH (500 ng/ml), testosterone (1 x
106 M), or dibutryl cAMP (1 x 10-4 M). Of the
hormones tested, only FSH induced a significant
increase in PKI activity; it was also found that
dibutyryl cAMP could mimic the effect ofFSH (14).
These results demonstrate that protein kinase
inhibitor in the Sertoli cell is regulated by FSH in
vitro. These data corroborate previous results
obtained in vivo (12) demonstrating that FSH
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FIGURE 3. Stimulation of PKI by FSH in vitro. Sertoli cells
were cultured for 48 hr in the absence ofFSH, then for up to
24 hr in the presence of 500 ng/ml FSH (solid line). Control
cultures (broken line) were maintained for the same period of
time in the absence ofFSH. Each point represents the mean
± SEM for 3-6 cultures (14).
specifically stimulates PKI activity in both normal
and Sertoli cell-enriched testes from immature
rats. In order to test whether the increased PKI
activity resulted from increased synthesis, cyclo-
heximide, a specific inhibitor ofprotein translation,
was used. In the presence ofcycloheximide alone no
change in basal PKI activity was observed. Fur-
thermore, no change in basal levels of protein
synthesis as measured by incorporation of [3H]
leucine into TCA-precipitable material was observed.
However, the addition of FSH to Sertoli cells
containing cycloheximide failed to induce a re-
sponse in PKI activity (15). These results suggest
that the increased PKI activity found in the pres-
ence ofFSH results from increased protein synthe-
sis. The in vitro regulation of PKI synthesis was
further evaluated in vitro. [35S]methionine was
added to cultured Sertoli cells and the incorporation
of this labeled amino acid into protein kinase
inhibitor was measured by precipitating the PKI
with amonospecific PKI antibody. In the absence of
dibuytryl cAMP, basal levels of [35S]methionine
incorporated into PKI precipitable material was
very low. However, in the presence of dibutryl
cAMP a 50-fold increase in [35S]methionine incorpo-
ration was observed. In contrast, only a 23%
increase incorporation of [35S] into total TCA-
precipitable was observed (15). These results sug-
gest that FSH induces de novo synthesis of PKI in
Sertoli cells.
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Another protein in the Sertoli cell which is
stimulated by FSH is androgen binding protein
(ABP). This protein is secreted by the Sertoli cell
and transported through the efferent duct to the
epididymis. It is thought to maintain high concen-
trations of androgen within the lumen by binding
with high affinity. However, the biological function
ofABP remains to be elucidated. Nonetheless ABP
serves as an excellent marker for Sertoli cell
function (16).
FSH was found to stimulate ABP in intact testes
(17, 18), Sertoli cell-enriched rat testes (19), iso-
lated seminiferous tubules (20), and Sertoli cells
maintained in primary culture (21, 22). Although
highly purified FSH elicited a response in vivo,
there was no stimulation with thyroid stimulating
hormone, prolactin or growth hormone. Luteinizing
hormone stimulates ABP activity to varying de-
grees in vivo, howeverthis may be due to its effects
on testosterone synthesis (19). The response of
ABP to FSH is related to the dose of FSH
administered (23). Equivalent doses of different
preparations of FSH gave similar dose-response
curves in both the ABP assay and the ovarian
weight augmentation test in hypophysectomized
rats suggesting that FSH was the biological stimu-
lus for both responses (24).
Testosterone will maintain spermatogenesis in
the absence of FSH (25). Specific receptors for
testosterone have been demonstrated in the Sertoli
cell and may be involved in regulating the biological
effects of this steroid on germ cells within the
seminiferous tubules (26). However, until recently
(27), there have been no documented responses of
the Sertoli cell to testosterone. Testosterone will
stimulate androgen binding protein activity in vivo.
This has been demonstrated both acutely (28) and
chronically (29). However, the acute stimulation
appears to result from 3tabilization ofthe protein in
the presence of ligand (30), whereas chronic treat-
ment is more closely correlated with production of
ABP. Chronic treatment of hypophysectomized
rats with testosterone has demonstrated that this
steroid will maintain normal levels of ABP in the
apparent absence of FSH (31).
When testosterone is administered together with
FSH in vivo an augmentation ofthe ABP response
above that found with FSH alone is observed (17).
This increased binding activity might be due to a
synergism between testosterone and FSH. How-
ever, the increased binding may also have been due
to the stabilizing influence oftestosterone. In order
to test these two possibilities, rats were injected
for 4 days with either testosterone propionate,
8
FSH or a combination ofthe two hormones (23). In
rats treated with highly purified FSH for 4 days, no
difference was found between these and the
testosterone-treated rats. However, if the FSH
treated testes were homogenized in the presence of
stabilizing factors, a fourfold increase in binding
activity was observed and no further change was
seen in rats treated with FSH and testosterone
propionate in vivo. These results demonstrated
that testosterone, whether injected in vivo or
included in the homogenization buffer, results in
stabilization ofany ABP present-in the testis. Thus,
the apparent synergism between testosterone and
FSH is due to the stabilizinginfluence ofthe steroid
on ABP binding activity. However, this does not
rule out possible direct effects of testosterone in
vivo on ABP production which were described
previously.
There has been much confusion over which hor-
mone, FSH or testosterone, regulates androgen
binding protein. This has been complicated by a
number of factors. These include the age of the
animal, thelengthoftimefollowinghypophysectomy
before hormone administration, and the dose of
hormone. ABP secretion in immature rats less than
three weeks of age, i.e., before lumen formation
and secretion begins, has an absolute requirement
for FSH (32). This cannot be replaced by testoster-
one. Even when secretion begins at about 16 days,
administration oftestosterone with FSH results in
the abolishment ofABP secretion into the epididy-
mis. This inhibitory effect of testosterone is not
observed in rats 21 days or older. After 21 days of
age, administration of testosterone propionate in
large doses for 10 days will maintain levels of ABP
similar to noninjected controls even though both
FSH and LH are suppressed (33). Furthermore,
FSH administration to older rats results in in-
creased ABP binding activity in a dose-dependent
manner (23).
Previous results suggested that changes in
microfilament distribution could alter Sertoli cell
shape and that cyclic AMP or low external calcium
concentration (EGTA) could affect microfilaments
in Sertoli cells (8). We then measured ABP secre-
tion by isolated cells to see if EGTA would affect
secretion. As shown in Table 1, EGTA caused rapid
release ofABP, and cytochalasin B interfered with
theEGTAeffect. Theresults suggestedinvolvement
of microfilaments in the process of secretion of
ABP.
The hormonal regulation of ABP secretion has
been studied in vitro with testicular minces (34),
explants (35) and Sertoli cells grown in culture (2,
21, 22, 36). However, these studies have not been
asinformativeasinitiallyhopedinthatthespecificity
Environmental Health PerspectivesTable 1. Sertoli cell secretion of ABP.a
Treatment Time, hr ABP, pmole/ml
Control 12 0.03
FSH 12 0.33
EGTA 1 0.28
Cytochalasin B 1 0.01
EGTA + cytochalasin 1 0.04
a Sertoli cellswereisolatedfromSertolicell-enriched 16-day-old
rats. Cells were incubated as duplicate samples in Eagle's
minimal essential medium (containing no serum) at 37°C under
02/CO2 (95%/5%) in ashakerbath. Medium was assayed for ABP
by steady-state polyacrylamide gel electrophoresis. FSH treat-
ment was 10 ,ug/ml, EDTA was 4 mM and cytochalasin B was 10
,ug/ml (8).
of the hormonal response is still unclear. Not only
FSH but also TSH stimulates ABP in vitro. More-
over, testosterone appears to cause increased ABP
secretion independently of FSH. Cortisol and
5a-androstane-3a,171-diol resulted in significant
elevation of ABP at early intervals following cell
plating, buttheseresponses disappeared withlonger
intervals ofincubation. Even the presence ofbovine-
serum albumin caused elevated ABP activity in
vitro as did whole serum from several species.
Another problem with in vitro systems has been
that the daily secretion rate of ABP gradually
decreases even in the presence of hormones, al-
though this is not evident if data are expressed as
cumulative secretion. More studies are needed to
evaluate the exact conditions necessary to maintain
the integrity of the Sertoli cell and its secretory
capacity in vitro. Once the proper environment for
the Sertoli cell is established, one factor at a time
can be removed in order to study its effect on
secretory activity. Only then can we begin to fully
understand the mechanisms by which ABP is
regulated in the Sertoli cell.
Summary
Results from our laboratory indicate that FSH is
a primary regulator of Sertoli cell function. A
variety of molecular events are observed following
FSH administration to Sertoli cells in culture.
Initially there is binding of FSH to plasma mem-
brane receptors, followed by activation ofadenylyl
cyclase. This increases intracellular concentrations
of cAMP which bind to the regulatory subunit of
protein kinase causing release of the catalytic
subunit. Protein kinase catalytic subunit phospho-
rylates specific proteins. These events are followed
by increased protein synthesis and secretion by the
Sertoli cell.
Protein kinase inhibitor activity is stimulated in
the Sertoli cell in response to FSH. The increase in
activity is due to FSH-regulation at the level of
PKI synthesis. This protein will serve as a useful
intracellular marker for FSH action in the Sertoli
cell. Another protein which is regulated by FSH is
the secretory protein, androgen binding protein.
The activity ofABP is regulated not only by FSH,
but also testosterone. Whether synthesis of this
protein is regulated by both hormones remains to
be determined. We have recently developed a
monospecific antibody to ABP (37) and therefore
should be able to examine this question by measur-
ing incorporation of labeled amino acids into the
protein.
Studies ofthe effects oftoxic agents on the testis
can be meaningful only by understanding the basic
biological mechanisms involved in regulating sper-
matogenesis. We have elucidated some basic mech-
anisms by which hormones regulate the Sertoli cell.
Byusing specific endpoint determinants ofhormone
action, such as protein kinase inhibitor and andro-
gen binding protein, we can begin to examine the
effects of toxic agents on spermatogenesis.
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